Bioventus (BVS) Finished Goods (2020 - 2026)

Bioventus (BVS) has reported Finished Goods for 7 consecutive years, with $61.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Finished Goods fell 15.86% year-over-year to $61.4 million; the trailing twelve-month figure through Jun 2026 stood at $61.4 million (down 15.86% YoY), and the FY2025 full-year result was $61.0 million, down 13.33% from the prior year.
• Finished Goods fell to $61.4 million in Q2 2026 per BVS's latest filing, from $63.9 million in the prior quarter.
• Across five years, Finished Goods topped out at $75.0 million in Q3 2023 and bottomed at $51.7 million in Q2 2022.
• Historically, Finished Goods has averaged $66.2 million across 5 years, with a median of $66.4 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Finished Goods jumped 75.2% in 2022, then decreased 15.86% in 2026.
• Over 5 years, Finished Goods stood at $66.3 million in 2022, then gained by 5.97% to $70.3 million in 2023, then rose by 0.15% to $70.4 million in 2024, then declined by 13.33% to $61.0 million in 2025, then increased by 0.73% to $61.4 million in 2026.
• According to Business Quant data, Finished Goods over the past three periods registered $61.4 million, $63.9 million, and $61.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.